Skip to content Skip to navigation

Drug Testing

Kratom research sorely needed for clinical, policy decisions

October 13, 2016  |  Julie Miller, Editor in Chief
article

In response to advocacy groups and congressional leaders, the Drug Enforcement Administration halted its attempt to place kratom on the list of Schedule I drugs, however, experts recommend more research on its pharmacology moving forward.

Claims study quantifies growing impact of opioid crisis

September 13, 2016  |  Julie Miller, Editor in Chief
article

Commercial health insurers paid treatment centers and other providers $445.7 million to treat plan members’ opioid dependence and abuse in 2015, demonstrating a 1,375% spending increase over five years.

Insurer drops drug screen requirement for hep C coverage

September 13, 2016  |  Tom Valentino, Senior Editor
news

As part of a $300 million settlement, UnitedHealthcare will no longer require policyholders to demonstrate abstinence from drugs and alcohol for six months before receiving coverage for a costly hepatitis C medication.

UnitedHealth names labs, treatment centers in federal fraud case

May 2, 2016  |  Julie Miller, Editor in Chief
article

UnitedHealth and its Florida affiliate filed a $50 million federal lawsuit against several testing labs, treatment centers and individuals, alleging financial kickbacks, fraud and other complaints.

New group funds patient copays for treatment

April 13, 2016  |  Julie Miller, Editor in Chief
article

The new not-for-profit Insured Consumer Access Network (ICAN) will provide scholarships for patients' out-of-pocket costs for treatment within a network of ethical providers.

Growth trend continued in Q4 of 2015

February 26, 2016  |  Julie Miller, Editor in Chief
article

Here's a roundup of 2015 earnings reports for Acadia, American Addiction Centers and Universal Health Services. Acquisitions and new growth after a potential change to the IMD exclusion were key issues.

Insurance warriors fight for coverage

December 23, 2015  |  Jill Sederstrom
article

With increased insurance coverage, more providers will encounter the frustration of meeting the preauthorization demands of payers. The key is to fight like an insurance warrior.

Payers open to 5 year treatment plan

November 2, 2015  |  Julie Miller, Editor in Chief
article

Payers want to know who the best addiction treatment providers are and how to get the best return. The Independent Coalition of Treatment Providers aims to answer those questions.

BREAKING: Calloway Labs will close this month

October 8, 2015  |  Gary A. Enos. Contributing Editor
news

Drug testing company Calloway Laboratories, which in recent years had been embroiled in controversies over improper government payments, is citing "unforeseen circumstances" in its decision to cease operation on Oct. 16.

11 strategies for change in the war on drugs

August 3, 2015  |  Julia Brown, Associate Editor
article

Prescription drugs and opioids have changed the game. Here's how you can help, according to NCAD speaker Frank Greenagel, LCSW, LCADC. 

Urine drug testing model likely to roll out nationwide

July 17, 2015  |  Julie Miller, Editor in Chief
article

The model does not allow for reimbursement when a presumptive test at a lab is used to confirm a presumptive test from the point of care.

How states manage hepatitis C drugs

July 1, 2015  |  Julie Miller, Editor in Chief
news

Authors say there is no justification for withholding hepatitis C treatment for individuals who use injected drugs, and yet, a majority of states restrict access for that population.

Pages

Subscribe to Drug Testing